Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

1.0K
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
1.0K
Acid Attack on Concrete01:21

Acid Attack on Concrete

907
When acids come into contact with concrete, they initiate a chemical reaction that dissolves the hydrated cement paste. This process leads to softening and structural weakening of the concrete. This issue is commonly observed in environments such as chimneys, sewers, and industrial settings. The severity of the damage increases as the pH of the water interacting with the concrete drops below 6.5. In particular, a pH under 4.5 can cause significant concrete damage.
The rate at which hydrogen...
907
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

5.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
5.4K
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

526
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
526
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

55
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
55
Titration of Polyprotic Base with a Strong Acid01:18

Titration of Polyprotic Base with a Strong Acid

6.1K
The titration of a polyprotic base such as sodium carbonate with a strong acid such as hydrochloric acid results in two equivalence points on the titration curve. At the first equivalence point, the carbonate ions in the base are completely converted to bicarbonate ions. The second equivalence point corresponds to the complete conversion of bicarbonate ions to carbonic acid, which dissociates into carbon dioxide and water. The region before the first equivalence point corresponds to the...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metaheuristic-optimized bell-shaped slotted pentaband patch antenna for C, X, Ku, and K band applications.

Scientific reports·2026
Same author

Closed-Loop Recycling of Poly(pentylene Adipate-co-Terephthalate) via Amine-Catalyzed Methanolysis.

ChemSusChem·2026
Same author

Glomus Tumor of the Face: A Case Report and Literature Review.

Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India·2025
Same author

DNA methylation landscapes of HIV controllers: an epigenome-wide association study.

EBioMedicine·2025
Same author

Biobased Poly(dodecylene Furanoate) with Inherent Advantages in Performance and Circularity.

ChemSusChem·2025
Same author

Sensory Nerve Transfer for Intractable Neuropathic Pain in a Case of C<sub>8</sub>-T<sub>1</sub> Root Avulsion in Brachial Plexus Injury.

The journal of hand surgery Asian-Pacific volume·2025

Related Experiment Video

Updated: Mar 12, 2026

Optimized Procedure for Determining the Adsorption of Phosphonates onto Granular Ferric Hydroxide using a Miniaturized Phosphorus Determination Method
08:21

Optimized Procedure for Determining the Adsorption of Phosphonates onto Granular Ferric Hydroxide using a Miniaturized Phosphorus Determination Method

Published on: May 18, 2018

15.2K

Alkaptonuric Ochronosis.

Onkar Singh1, Rajadoss Muthukrishna Pandian1, Nitin Sudhakar Kekre1

  • 1Department of Urology, Christian Medical College and Hospital, Vellore, Tamilnadu, India.

Urology
|November 7, 2016
PubMed
Summary
This summary is machine-generated.

Alkaptonuria, a rare metabolic disorder, causes homogentisic acid buildup, leading to dark urine and tissue deposition. This case highlights its impact on the urinary tract with bladder and prostate stones.

More Related Videos

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

4.1K
Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
09:23

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability

Published on: June 21, 2015

10.3K

Related Experiment Videos

Last Updated: Mar 12, 2026

Optimized Procedure for Determining the Adsorption of Phosphonates onto Granular Ferric Hydroxide using a Miniaturized Phosphorus Determination Method
08:21

Optimized Procedure for Determining the Adsorption of Phosphonates onto Granular Ferric Hydroxide using a Miniaturized Phosphorus Determination Method

Published on: May 18, 2018

15.2K
Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

4.1K
Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
09:23

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability

Published on: June 21, 2015

10.3K

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Alkaptonuria is a rare autosomal recessive metabolic disorder caused by homogentisate 1,2 dioxygenase deficiency.
  • This deficiency leads to the accumulation of homogentisic acid and its oxidized metabolites in connective tissues.
  • Clinical manifestations include ochronosis, arthritis, and urolithiasis.

Observation:

  • A patient with alkaptonuria presented with symptoms of lower urinary tract issues.
  • The symptoms were attributed to the presence of vesical and prostatic calculi.
  • This indicates significant multi-system involvement in the presented case.

Findings:

  • The case demonstrates alkaptonuria's association with bladder and prostate stone formation.
  • Homogentisic acid deposition contributes to urolithiasis in alkaptonuria patients.
  • This presentation underscores the diverse clinical spectrum of alkaptonuria.

Implications:

  • Early diagnosis and management of alkaptonuria are crucial to prevent systemic complications.
  • Understanding the link between alkaptonuria and urolithiasis can guide clinical suspicion and treatment.
  • Further research into alkaptonuria's multi-system effects is warranted for comprehensive patient care.